Alignment Healthcare, Inc. (ALHC) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$18.30
Price Target
$24.83
Target Range
$19.00 — $30.00
Analyst Rating
Buy
Forward P/E141.3x
Trailing P/E-4945.9x
Forward PEG—
Implied Growth+39.4%
Median Target$25.00
Analyst Spread44.3%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$19
+3.8%
Consensus
$25
+35.7%
Bull Case
$30
+63.9%
ALHC Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Alignment Healthcare, Inc. (ALHC) has a Wall Street consensus price target of $24.83, based on estimates from 16 covering analysts. With the stock currently trading at $18.30, this represents a potential upside of +35.7%. The company has a market capitalization of $3.74B.
Analyst price targets range from a low of $19.00 to a high of $30.00, representing a 44% spread in expectations. The median target of $25.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ALHC trades at a trailing P/E of -4945.9x and forward P/E of 141.3x. Analysts expect EPS to grow +39.4% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+4.9%
Avg Forward P/E25.1x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CNCCentene Corporation | $26.2B | $52.97 | $51.00 | -3.7% | Buy | 15.7x | 43 |
 MOHMolina Healthcare, Inc. | $10.0B | $192.17 | $166.09 | -13.6% | Buy | 37.3x | 38 |
 CVSCVS Health Corporation | $102.6B | $80.69 | $95.20 | +18.0% | Buy | 11.3x | 41 |
 HUMHumana Inc. | $28.8B | $239.53 | $246.00 | +2.7% | Hold | 26.8x | 44 |
 ELVElevance Health Inc. | $80.1B | $369.07 | $382.38 | +3.6% | Buy | 13.8x | 37 |
 OSCROscar Health, Inc. | $4.7B | $17.94 | $16.75 | -6.6% | Hold | 29.8x | 11 |
 CLOVClover Health Investments, Corp. | $1.3B | $2.61 | $3.33 | +27.6% | Hold | 61.0x | 9 |
 ACGLArch Capital Group Ltd. | $33.5B | $94.14 | $104.00 | +10.5% | Buy | 10.0x | 34 |
 HCAIHauchen AI Parking Management Technology Holding Co., Ltd. | $17M | $15.52 | — | — | — | — | — |
 UNHUnitedHealth Group Incorporated | $330.3B | $363.87 | $385.43 | +5.9% | Buy | 19.9x | 52 |
Upside Potential Comparison
CLOVCVSACGLUNHELVHUMCNCOSCRSee ALHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ALHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ALHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonALHC — Frequently Asked Questions
Quick answers to the most common questions about buying ALHC stock.
What is the ALHC stock price target for 2026?
The consensus Wall Street price target for ALHC is $24.83, representing 35.7% upside from the current price of $18.3. With 16 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is ALHC a buy, sell, or hold?
ALHC has a consensus rating of "Buy" based on 16 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $24.83 implies 35.7% upside from current levels.
Is ALHC stock overvalued or undervalued?
At a forward P/E of 141.3127x, ALHC trades at a premium valuation. The consensus price target of $24.83 (35.7% upside) suggests analysts still see growth justifying the multiple.
How high can ALHC stock go?
The most bullish Wall Street analyst has a price target of $30 for ALHC, while the most conservative target is $19. The consensus of $24.83 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover ALHC stock?
ALHC is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 13 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ALHC stock forecast?
The 12-month ALHC stock forecast based on 16 Wall Street analysts shows a consensus price target of $24.83, with estimates ranging from $19 (bear case) to $30 (bull case). The median consensus rating is "Buy".
What is ALHC's forward P/E ratio?
ALHC trades at a forward P/E ratio of 141.3x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ALHC stock?
Wall Street analysts are very optimistic on ALHC, with a "Buy" consensus rating and $24.83 price target (35.7% upside). 14 of 16 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ALHC price targets vary so much?
ALHC analyst price targets range from $19 to $30, a 44% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $24.83 consensus represents the middle ground.